ICU Medical Inc (ICUI)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $4.55B
Last updated: Nov 17, 2026 at 4:10 PM ET
ICU Medical Inc (ICUI) Statistics
ICU Medical (ICUI) has a market cap of $4.55B and an enterprise value of $5.40B. Its return on invested capital of 3.22% compares with a 7.13% median across 9 similar companies.
Total Valuation
Enterprise value is 18.69% above the market cap, as debt exceeds cash.
| Market Cap | $4.55B |
|---|---|
| Enterprise Value | $5.40B |
| Latest price (Nov 17, 2026) | $176.91 |
Key Dates
The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.0x and 2.0x. Its year-end P/E ranged from 14.8x to 33.0x from 2016 to 2025.
| P/E Ratio | 22.1x |
|---|---|
| Forward P/E | 19.5x |
| P/S Ratio | 2.0x |
| Forward P/S | 2.1x |
| P/B Ratio | 2.0x |
| P/TBV Ratio | 25.7x |
| P/FCF Ratio | 21.2x |
| P/OCF Ratio | 16.3x |
| PEG Ratio | 1.9 |
Enterprise Valuation
Counting debt and cash, the company is valued at 16.2x EBITDA and 25.3x free cash flow.
| EV / Earnings | 89.5x |
|---|---|
| EV / Sales | 2.5x |
| EV / EBITDA | 16.2x |
| EV / EBIT | 50.2x |
| EV / FCF | 25.3x |
Price Statistics
The stock is up 29.60% over 52 weeks and trades 7.66% above its 50-day average.
| Beta (1Y) | 1.06 |
|---|---|
| 52-Week Change | +29.60% |
| 1-Month Change | +9.72% |
| 3-Month Change | -5.53% |
| 6-Month Change | +43.06% |
| 5-Year Change | -30.05% |
| 10-Year Change | +17.57% |
| Total Return (1Y) | +29.60% |
| Total Return (3Y CAGR) | +27.38% |
| Total Return (5Y CAGR) | -6.42% |
| Return vs SPY (1Y) | +20.43% |
| Max Drawdown (1Y) | -27.18% |
| Max Drawdown (3Y) | -41.20% |
| Sharpe Ratio (1Y) | 0.79 |
| Correlation with SPY (1Y) | 0.41 |
| 50-Day Average | $164.33 |
| 200-Day Average | $149.88 |
| 52-Week Range | $113.37 to $192.85 |
| RSI (14 Days) | 57.3 |
| Average Volume (20 Days) | 294.69K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.37x current liabilities, and total debt is 0.53x shareholder equity.
| Current Ratio | 2.37x |
|---|---|
| Quick Ratio | 1.19x |
| Debt / Equity | 0.53x |
| Debt / EBITDA | 3.53x |
| Debt / FCF | 5.52x |
| Interest Coverage | 1.58x |
Returns and Efficiency
Return on invested capital is 3.22% over the last 12 months, against a 5-year average of 0.49%.
| Return on Equity (ROE) | 2.75% |
|---|---|
| Return on Assets (ROA) | 1.53% |
| Return on Invested Capital (ROIC) | 3.22% |
| Return on Capital Employed (ROCE) | 3.14% |
| ROE (5Y Average) | -0.90% |
| ROA (5Y Average) | 0.08% |
| ROIC (5Y Average) | 0.49% |
| Asset Turnover | 0.54x |
| Inventory Turnover | 2.15x |
| Receivables Turnover | 11.20x |
| Cash Conversion Cycle | 162 days |
Scores
ICUI has an Altman Z-Score of 2.65, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.65 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $2.18B over the last 12 months is down 5.92% from the 12 months before.
| Revenue | $2.18B |
|---|---|
| Revenue Growth (YoY) | -5.92% |
| Gross Profit | $879.02M |
| Operating Income | $110.66M |
| Pretax Income | $39.45M |
| Net Income | $60.33M |
| EBITDA | $325.95M |
| EBIT | $107.57M |
| Reported EPS (TTM) | $8.00 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 55.58% of the $3.94B in total assets.
| Cash and Equivalents | $301.78M |
|---|---|
| Total Debt | $1.15B |
| Net Debt | $850.07M |
| Net Debt Per Share | $33.99 |
| Working Capital | $705.23M |
| Shareholder Equity | $2.19B |
| Book Value Per Share | $87.63 |
| Tangible Book Value | $172.17M |
| Tangible Book Per Share | $6.88 |
| Total Assets | $3.94B |
| Total Liabilities | $1.75B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $70.64M of capital spending, operating cash flow left $208.60M of free cash flow.
| Operating Cash Flow | $279.24M |
|---|---|
| Capital Expenditures | $70.64M |
| Free Cash Flow | $208.60M |
| FCF Per Share | $8.34 |
| Depreciation and Amortization | $225.13M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 5.07%, against a 5-year average of 2.44%.
| Gross Margin | 40.27% |
|---|---|
| Operating Margin | 5.07% |
| Pretax Margin | 1.81% |
| Net Margin | 2.76% |
| EBITDA Margin | 14.93% |
| EBIT Margin | 4.93% |
| FCF Margin | 9.56% |
| Gross Margin (5Y Average) | 34.43% |
| Operating Margin (5Y Average) | 2.44% |
| Net Margin (5Y Average) | -0.33% |
Growth
Revenue fell 0.72% a year over 3 years, and EPS grew 3.83% a year.
| Revenue Growth (3Y CAGR) | -0.72% |
|---|---|
| Revenue Growth (5Y CAGR) | +11.91% |
| EPS Growth (3Y CAGR) | +3.83% |
| EPS Growth (5Y CAGR) | +0.53% |
| FCF Growth (5Y CAGR) | -6.83% |
| Book Value Per Share Growth (2Y CAGR) | -1.10% |
Dividends and Yields
ICUI does not pay a dividend. Its free cash flow yield is 4.72%.
| Earnings Yield | 4.52% |
|---|---|
| FCF Yield | 4.72% |
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 3-for-2 forward split on Mar 18, 2002.
| Last Split Date | Mar 18, 2002 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 3:2 |
Peer Position
Against 10 similar companies, ICUI has the 4th highest P/E.
P/E RatioPeer median 20.1x
P/S RatioPeer median 2.9x
ROICPeer median 7.13%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.97%
| P/E Ratio | 22.1x vs 20.1x median |
|---|---|
| P/S Ratio | 2.0x vs 2.9x median |
| ROIC | 3.22% vs 7.13% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -5.92% vs +8.97% median |
Analyst Forecast
Consensus estimates put revenue growth at 1.27% and EPS growth at 14.98% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +1.27% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +14.98% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ICUI
What is ICUI's market cap?
ICU Medical has a market cap of $4.55B. Its enterprise value, which adds debt and subtracts cash, is $5.40B.
What is ICUI's P/E ratio?
ICU Medical has a trailing P/E ratio of 22.1x and a forward P/E of 19.5x.
How many shares of ICUI are outstanding?
ICU Medical has 25.01M shares outstanding. The count is up 1.30% from a year earlier.
Does ICUI pay a dividend?
No. ICU Medical does not pay a dividend.
How much debt does ICUI have?
ICU Medical has $1.15B of total debt and $301.78M of cash and equivalents, a net debt position of $850.07M.
ICUI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts